Ignite Creation Date:
2025-12-25 @ 12:41 AM
Ignite Modification Date:
2026-03-11 @ 11:44 PM
Study NCT ID:
NCT00587067
Status:
COMPLETED
Last Update Posted:
2023-04-04
First Post:
2007-12-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization: